Penny stocks to consider buying while their prices are this cheap
Some of the penny stocks I've been watching have already climbed above the 100p level. But I see potential in a number of others.
Source: fool.co.uk
📰 Poolbeg Pharma News
Poolbeg Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Poolbeg Pharma. Real-time updates on events, politics, business and more.
Glandore's Michael Kelly increases his stake in Poolbeg Pharma – The Irish Times
Most recent acquisition makes managing director the company’s second-largest shareholder after founder Cathal Friel
Source: irishtimes.com
Poolbeg Pharma plc - Significant POLB 001 Patent Granted in United States
Significant POLB 001 Patent Granted in United States  Immunomodulator II patent grant further strengthens robust intellectual property portfolio for partnering   1 May 2024– Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company...
Source: pharmiweb.com
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in ...
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in ...
Source: pr-inside.com
Poolbeg Pharma granted significant POLB 001 patent in United States
Poolbeg Pharma plc (LON:POLB, OTCQB:POLBF) receives fully granted US patent for Immunomodulator II, enhancing value and attractiveness to potential Pharma partners.
Source: directorstalkinterviews.com
Poolbeg Pharma celebrates full patent approval for Immunomodulator II
Poolbeg Pharma PLC on Wednesday said that it has received a fully granted patent from the US Patent Office for its Immunomodulator II patent application. According to the London-based clinical-stage...
Source: marketscreener.com
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug ...
Source: pr-inside.com
Poolbeg Pharma expand treatment into new markets
Company signs strategic collaboration agreement with a Nasdaq listed biopharma company
Poolbeg Pharma Amryt Pharma Jeremy Skillington Brendan Buckley Cytokine Release Syndrome Cytokine Release
Source: irishtimes.com
Poolbeg Pharma's POLB 001 has great potential to generate significant value for shareholders
Poolbeg Pharma plc announces audited results for 2023, highlighting financial, corporate, and operational achievements. CEO Jeremy Skillington emphasizes potential for significant value creation.
Source: directorstalkinterviews.com
Poolbeg Pharma enters Exclusive Option Agreement for novel Behçet's Disease treatment
Poolbeg Pharma plc has entered into an exclusive agreement with Silk Road Therapeutics for a novel treatment targeting oral ulcers in Behçet's Disease patients.
Jeremy Skillington Poolbeg Pharma Therapeutics Inc Silk Road Therapeutics Inc Silk Road Therapeutics Secured Orphan Drug Designation
Source: directorstalkinterviews.com